ClinicalTrials.gov
public full text
Public Domain
Cathodal tDCS in Chronic Migraine: Neurophysiological Study and Pilot Therapeutic Trial
Cathodal tDCS decreases the excitability of the cerebral cortex and its daily application during intercritical phase, may have a therapeutic effect in chronic migraine.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Neurophysiology of Prophylactic Treatment in Migraine#865776
- Migraine: Epidemiology, Risk Factors, Pathophysiology, and Treatment.#630987
- Non-invasive Brain Stimulation for the Treatment of Psychiatric Disorders#838140
- Efficacy, Safety, and Tolerability of Oral Ubrogepant in the Acute Treatment of Migraine#871658
- Atogepant reduces triptan use: a pharmacoeconomic analysis in migraine prevention.#312477
Record · ID 909669
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive